HK46196A - Treatment of leukocyte dysfunction with gm-csf - Google Patents
Treatment of leukocyte dysfunction with gm-csfInfo
- Publication number
- HK46196A HK46196A HK46196A HK46196A HK46196A HK 46196 A HK46196 A HK 46196A HK 46196 A HK46196 A HK 46196A HK 46196 A HK46196 A HK 46196A HK 46196 A HK46196 A HK 46196A
- Authority
- HK
- Hong Kong
- Prior art keywords
- csf
- dysfunction
- treating
- treatment
- leukocyte
- Prior art date
Links
- 230000004064 dysfunction Effects 0.000 title abstract 5
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 title abstract 4
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 title abstract 4
- 210000000265 leukocyte Anatomy 0.000 title abstract 4
- 238000000034 method Methods 0.000 abstract 3
- 241000124008 Mammalia Species 0.000 abstract 2
- 208000014674 injury Diseases 0.000 abstract 2
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30439189A | 1989-01-30 | 1989-01-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK46196A true HK46196A (en) | 1996-03-22 |
Family
ID=23176323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK46196A HK46196A (en) | 1989-01-30 | 1996-03-14 | Treatment of leukocyte dysfunction with gm-csf |
Country Status (21)
Country | Link |
---|---|
US (1) | US5178855A (fr) |
EP (2) | EP0382381B1 (fr) |
JP (1) | JPH0651640B2 (fr) |
KR (1) | KR0137361B1 (fr) |
AT (1) | ATE89737T1 (fr) |
AU (1) | AU633054B2 (fr) |
CA (1) | CA2045605C (fr) |
DE (1) | DE69001686T2 (fr) |
DK (1) | DK0382381T3 (fr) |
ES (1) | ES2055314T3 (fr) |
FI (1) | FI913625A0 (fr) |
HK (1) | HK46196A (fr) |
HU (1) | HU207229B (fr) |
IE (1) | IE64234B1 (fr) |
IL (1) | IL93219A (fr) |
MY (1) | MY105798A (fr) |
NZ (1) | NZ243953A (fr) |
OA (1) | OA09509A (fr) |
PT (1) | PT92995B (fr) |
WO (1) | WO1990008554A1 (fr) |
ZA (1) | ZA90600B (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0526630A4 (en) * | 1991-02-22 | 1993-08-11 | Amgen Inc. | Use of gm-csf and g-csf to promote accelerated wound healing |
GB9120304D0 (en) * | 1991-09-24 | 1991-11-06 | Erba Carlo Spa | Stable pharmaceutical compositions containing a granulocyte macrophage colony stimulating factor |
WO1994028919A1 (fr) * | 1993-06-08 | 1994-12-22 | Ajinomoto Co., Inc. | Accelerateur de la proliferation des cellules hematopietiques |
JPH09509828A (ja) * | 1994-03-04 | 1997-10-07 | ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ | 標的遺伝子損傷をした動物 |
US5942253A (en) | 1995-10-12 | 1999-08-24 | Immunex Corporation | Prolonged release of GM-CSF |
US7153943B2 (en) | 1997-07-14 | 2006-12-26 | Bolder Biotechnology, Inc. | Derivatives of growth hormone and related proteins, and methods of use thereof |
US20080076706A1 (en) | 1997-07-14 | 2008-03-27 | Bolder Biotechnology, Inc. | Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof |
US6753165B1 (en) * | 1999-01-14 | 2004-06-22 | Bolder Biotechnology, Inc. | Methods for making proteins containing free cysteine residues |
US8288126B2 (en) | 1999-01-14 | 2012-10-16 | Bolder Biotechnology, Inc. | Methods for making proteins containing free cysteine residues |
US6911204B2 (en) | 2000-08-11 | 2005-06-28 | Favrille, Inc. | Method and composition for altering a B cell mediated pathology |
EP2124897A4 (fr) * | 2006-12-22 | 2012-05-09 | Novadel Pharma Inc | Préparations antinauséeuses à pulvériser, à usage oral, stables, et méthodes associées |
US7648379B2 (en) | 2007-08-09 | 2010-01-19 | Haworth, Inc. | Modular electrical distribution system for a building |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5078996A (en) * | 1985-08-16 | 1992-01-07 | Immunex Corporation | Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor |
WO1987002060A1 (fr) * | 1985-10-03 | 1987-04-09 | Biogen N.V. | Polypeptides semblables aux facteurs de stimulation de colonies de granulocytes-macrophages (gm-csf) et leurs procedes de production en quantites importantes dans des cellules microbiennes |
JPH0618778B2 (ja) * | 1985-10-04 | 1994-03-16 | 中外製薬株式会社 | 白血球減少症治療剤 |
AU589731B2 (en) * | 1985-11-27 | 1989-10-19 | Genetics Institute, Llc | Colony stimulating factor for the treatment of aids-type diseases |
WO1987006954A1 (fr) * | 1986-05-06 | 1987-11-19 | Genetics Institute, Inc. | Production de m-csf |
US5162111A (en) * | 1986-07-30 | 1992-11-10 | Grabstein Kenneth H | Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor |
EP0276846A3 (fr) * | 1987-01-29 | 1989-07-26 | Zymogenetics, Inc. | Dérivés du facteur stimulant des colonies |
WO1989004173A1 (fr) * | 1987-11-12 | 1989-05-18 | Schering Corporation | Acceleration de formation osseuse a l'aide de gm-csf |
-
1990
- 1990-01-26 HU HU901977A patent/HU207229B/hu not_active IP Right Cessation
- 1990-01-26 CA CA002045605A patent/CA2045605C/fr not_active Expired - Fee Related
- 1990-01-26 MY MYPI90000141A patent/MY105798A/en unknown
- 1990-01-26 ZA ZA90600A patent/ZA90600B/xx unknown
- 1990-01-26 DK DK90300840.7T patent/DK0382381T3/da active
- 1990-01-26 JP JP2503253A patent/JPH0651640B2/ja not_active Expired - Lifetime
- 1990-01-26 NZ NZ243953A patent/NZ243953A/en unknown
- 1990-01-26 US US07/721,586 patent/US5178855A/en not_active Expired - Fee Related
- 1990-01-26 ES ES90300840T patent/ES2055314T3/es not_active Expired - Lifetime
- 1990-01-26 EP EP90300840A patent/EP0382381B1/fr not_active Expired - Lifetime
- 1990-01-26 EP EP90903118A patent/EP0455726A1/fr active Pending
- 1990-01-26 DE DE9090300840T patent/DE69001686T2/de not_active Expired - Fee Related
- 1990-01-26 AU AU50488/90A patent/AU633054B2/en not_active Ceased
- 1990-01-26 AT AT90300840T patent/ATE89737T1/de not_active IP Right Cessation
- 1990-01-26 KR KR1019900702160A patent/KR0137361B1/ko not_active IP Right Cessation
- 1990-01-26 WO PCT/US1990/000379 patent/WO1990008554A1/fr not_active Application Discontinuation
- 1990-01-29 PT PT92995A patent/PT92995B/pt not_active IP Right Cessation
- 1990-01-29 IE IE31890A patent/IE64234B1/en not_active IP Right Cessation
- 1990-01-30 IL IL9321990A patent/IL93219A/en not_active IP Right Cessation
-
1991
- 1991-07-23 OA OA60047A patent/OA09509A/en unknown
- 1991-07-30 FI FI913625A patent/FI913625A0/fi not_active Application Discontinuation
-
1996
- 1996-03-14 HK HK46196A patent/HK46196A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0382381B1 (fr) | 1993-05-26 |
DE69001686D1 (de) | 1993-07-01 |
EP0382381A1 (fr) | 1990-08-16 |
JPH0651640B2 (ja) | 1994-07-06 |
PT92995B (pt) | 1995-12-29 |
DK0382381T3 (da) | 1993-07-12 |
AU633054B2 (en) | 1993-01-21 |
IE900318L (en) | 1990-07-30 |
ES2055314T3 (es) | 1994-08-16 |
CA2045605C (fr) | 1997-02-11 |
WO1990008554A1 (fr) | 1990-08-09 |
IE64234B1 (en) | 1995-07-26 |
HU207229B (en) | 1993-03-29 |
HUT57607A (en) | 1991-12-30 |
KR0137361B1 (ko) | 1998-04-25 |
OA09509A (en) | 1992-11-15 |
MY105798A (en) | 1995-01-30 |
FI913625A0 (fi) | 1991-07-30 |
PT92995A (pt) | 1990-07-31 |
NZ243953A (en) | 1997-06-24 |
EP0455726A1 (fr) | 1991-11-13 |
ATE89737T1 (de) | 1993-06-15 |
US5178855A (en) | 1993-01-12 |
DE69001686T2 (de) | 1993-09-02 |
ZA90600B (en) | 1990-10-31 |
IL93219A0 (en) | 1990-11-05 |
CA2045605A1 (fr) | 1990-07-31 |
AU5048890A (en) | 1990-08-24 |
KR910700069A (ko) | 1991-03-13 |
IL93219A (en) | 1998-12-27 |
JPH03504980A (ja) | 1991-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW265265B (fr) | ||
HUT63564A (en) | Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine | |
BG60253B1 (bg) | Човешки тъканен плазминогенен активатор | |
IT8419266A1 (it) | Dispositivo per generare calore in tessuti" del corpo umano e procedimento di cenerazione di calore, particolarmente per la cura di tumori | |
EP0317568A4 (fr) | Utilisation de stimulation de colonies de granulocytes-macrophage pour l'obtention d'un médicament pour le traitement de maladies bacteriènnes. | |
IL93219A0 (en) | Treatment of leukocyte dysfunction with gm-csf | |
GR3032224T3 (en) | Therapeutic agent for threatened abortion. | |
KR870010871A (ko) | 재조합 인체 알파 인터페론에 의한 기저세포 암종의 병소내적 치료방법 | |
GR3000751T3 (en) | Tpa-containing medical composition and use thereof | |
EP0397211A3 (fr) | Administration percutanée de la 3'-azido-3'-déoxythymidine | |
KR900701311A (ko) | 재조합 사람 α-인터페론을 병소내로 투여하여 편평세포 암을 치료하는 방법 | |
IT1246050B (it) | Impiego dell'eptastigmina nella terapia dell'ictus cerebrale. | |
粟坪华 et al. | Observation on 38 cases of drug-induced myospasm treated with massage over the acupoints | |
周荣兴 et al. | THE EFFECT OF ACUPUNCTURE ON THE PHAGOCYTIC ACTIVITY OF HUMAN LEUKOCYTES | |
Bantz et al. | Ciprofloxacin treatment of deep respiratory tract infections. | |
Lowe et al. | Subcutaneous ancrod therapy in peripheral arterial disease: improvement in blood viscosity and nutritional blood flow. | |
EP0282844A3 (en) | Use of dopamine-agonists in the preparation of a medicament for the treatment of bone injuries | |
IL125789A (en) | USE OF A DELETION VARIANT HUMAN t-PA PROTEIN IN THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF VASCULAR DISEASES | |
HUT54302A (en) | Process for producing medicaments comprising gamma-interferon, suitable for treating cancer of the ovary | |
RU96115809A (ru) | Способ лечения сочетанной челюстно-мозговой травмы |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |